N. E. Dal-Bekar Et Al. , "Development and validation of an LC-MS/MS method for D- and L-2-hydroxyglutaric acid measurement in cerebrospinal fluid, urine and plasma: application to glioma," BIOANALYSIS , no.19, pp.1271-1280, 2022
Dal-Bekar, N. E. Et Al. 2022. Development and validation of an LC-MS/MS method for D- and L-2-hydroxyglutaric acid measurement in cerebrospinal fluid, urine and plasma: application to glioma. BIOANALYSIS , no.19 , 1271-1280.
Dal-Bekar, N. E., Tuna, G., Islekel, S., & İşlekel, G. H., (2022). Development and validation of an LC-MS/MS method for D- and L-2-hydroxyglutaric acid measurement in cerebrospinal fluid, urine and plasma: application to glioma. BIOANALYSIS , no.19, 1271-1280.
Dal-Bekar, Nazli Et Al. "Development and validation of an LC-MS/MS method for D- and L-2-hydroxyglutaric acid measurement in cerebrospinal fluid, urine and plasma: application to glioma," BIOANALYSIS , no.19, 1271-1280, 2022
Dal-Bekar, Nazli E. Et Al. "Development and validation of an LC-MS/MS method for D- and L-2-hydroxyglutaric acid measurement in cerebrospinal fluid, urine and plasma: application to glioma." BIOANALYSIS , no.19, pp.1271-1280, 2022
Dal-Bekar, N. E. Et Al. (2022) . "Development and validation of an LC-MS/MS method for D- and L-2-hydroxyglutaric acid measurement in cerebrospinal fluid, urine and plasma: application to glioma." BIOANALYSIS , no.19, pp.1271-1280.
@article{article, author={Nazli Ecem Dal-Bekar Et Al. }, title={Development and validation of an LC-MS/MS method for D- and L-2-hydroxyglutaric acid measurement in cerebrospinal fluid, urine and plasma: application to glioma}, journal={BIOANALYSIS}, year=2022, pages={1271-1280} }